We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Explore the different types of leukemia: AML, ALL, CML, and CLL. Learn about their symptoms, causes, and the latest treatment advancements for better health outcomes.

Leukemia. The word itself can send a shiver down the spine. It’s a type of cancer that strikes at the very core of our being – our blood and bone marrow. Think of your bone marrow as a busy factory, churning out all sorts of blood cells: red blood cells to carry oxygen, white blood cells to fight off infections, and platelets to help stop bleeding. In leukemia, this factory goes haywire. It starts producing abnormal white blood cells, often called leukemia cells. These cells don't function like healthy ones. They crowd out the good cells, making it harder for your body to do its vital jobs. It’s a serious condition, but understanding it is the first step towards managing it. Let’s break down the different types, what to look out for, and the hopeful advancements in treatment.
At its heart, leukemia is a cancer of the blood-forming tissues. This typically includes the bone marrow and the lymphatic system. Instead of producing healthy, functional blood cells, the body starts making abnormal white blood cells. These abnormal cells, often referred to as leukemic blasts or leukemia cells, don't mature properly and don't function as they should. Worse, they multiply rapidly, overwhelming the production of normal, healthy blood cells. This imbalance can lead to a host of problems, from anemia (due to a lack of red blood cells) to increased susceptibility to infections (due to a lack of functional white blood cells) and bleeding issues (due to a shortage of platelets).
One of the most fundamental ways doctors classify leukemia is based on how quickly it progresses. This leads us to two main categories: acute and chronic.
Imagine a wildfire. That's a bit like acute leukemia. It develops very suddenly, often within days or weeks. The abnormal cells are immature, meaning they haven't had a chance to develop into fully functional cells. These immature cells, called blasts, multiply at an alarming rate. Because they are so primitive, they can't perform their normal duties. This rapid proliferation means acute leukemia requires immediate medical attention and aggressive treatment. Without prompt intervention, it can be life-threatening. The most common forms of acute leukemia are Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML).
Chronic leukemia, on the other hand, is more like a slow-burning ember. It develops more gradually, often over months or even years. The abnormal cells are more mature than in acute leukemia, and they can still perform some of their normal functions, at least initially. This is why people with chronic leukemia might not show any symptoms for a long time. They might even be diagnosed incidentally during a routine blood test. While it progresses more slowly, chronic leukemia still needs careful monitoring and treatment. The main types of chronic leukemia are Chronic Lymphocytic Leukemia (CLL) and Chronic Myeloid Leukemia (CML).
Now, let's dive deeper into the specific types of leukemia that affect people. The classification often depends on the type of white blood cell affected and whether it's acute or chronic.
AML is the most common type of acute leukemia in adults. It originates in the bone marrow and affects myeloid cells, which are cells that normally develop into various types of blood cells, including white blood cells, red blood cells, and platelets. AML progresses rapidly. The leukemic cells, called myeloblasts, multiply quickly and crowd out healthy cells. While it’s more common in adults, particularly older adults, AML can occur in children too. Early diagnosis and aggressive treatment are key for a better outcome.
ALL is the most common type of leukemia in children. However, it can also affect adults. This type of leukemia starts in the bone marrow and affects lymphoid cells, which are cells that normally develop into lymphocytes (a type of white blood cell). Like AML, ALL is an aggressive cancer that progresses quickly. Prompt treatment is essential.
CML is a chronic form of leukemia that primarily affects adults. It originates in the bone marrow and involves myeloid cells. CML is characterized by a specific genetic mutation known as the Philadelphia chromosome, which is found in about 95% of CML cases. This mutation causes the abnormal proliferation of granulocytes, a type of white blood cell. CML typically progresses slowly, and many people may not experience symptoms for years. It's estimated that about 15% of all adult leukemia cases are CML.
CLL is another chronic leukemia that predominantly affects adults, particularly those over 50. It originates in the bone marrow and affects lymphoid cells, leading to an overproduction of abnormal lymphocytes. CLL is the most common type of leukemia in adults in Western countries. It usually progresses very slowly, and many individuals live with it for years without significant symptoms. Some people may not even know they have it until it's detected during a routine blood test.
It's important to remember that these symptoms can also be caused by many other, less serious conditions. However, if you experience any of these persistently, it's wise to seek medical advice.
Hairy Cell Leukemia is a rare, slow-growing type of chronic leukemia that affects a specific type of white blood cell called B-lymphocytes. It gets its name from the distinctive
Overall, early action and medically verified advice remain the safest approach.
Understand the cost of a renal panel test in India. Learn about factors influencing price and how to get affordable diagnostics.
April 27, 2026
Understand the cost of ketone blood tests in India, factors influencing prices, and why this vital test matters for your health.
April 27, 2026
Discover how to find the best Ayurvedic doctors in India for holistic wellness and natural healing. Learn key factors and resources.
April 26, 2026